# A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis

> **NCT00293826** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 813 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** AMG 108
- **DRUG:** AMG 108
- **DRUG:** AMG 108
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00293826
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-11
- **Final completion:** 2008-02
- **Target enrollment:** 813 (ACTUAL)
- **Last updated:** 2010-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293826, "A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00293826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*